Skip to main content
Massimo Cristofanilli, MD, Oncology, New York, NY

MassimoCristofanilliMD

Oncology New York, NY

Breast Cancer, Hematologic Oncology

Professor of Medicine, Weill-Cornell Medicine/NYP

Overview of Dr. Cristofanilli

Dr. Massimo Cristofanilli is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from Sapienza University of Rome and has been in practice 31 years. Dr. Cristofanilli accepts several types of health insurance, listed below. He is one of 379 doctors at New York-Presbyterian Hospital and one of 379 doctors at New York-Presbyterian Hospital who specialize in Oncology. He also speaks multiple languages, including Italian. He has more than 100 publications and over 500 citings.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 1998
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1993 - 1996
  • Sapienza University of Rome
    Sapienza University of RomeClass of 1986

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2015 - 2026
  • NY State Medical License
    NY State Medical License 2022 - 2025
  • PA State Medical License
    PA State Medical License 2010 - 2016
  • TX State Medical License
    TX State Medical License 1997 - 2010
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
  • America's Top Doctors Castle Connolly, 2012-2014
  • Philadelphia Magazine Castle Connolly, 2012-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Minimal Residual Disease in Patients with Nonmetastatic Triple-Negative Breast Cancer  
    Massimo Cristofanilli, MD, JAMA Oncology
  • Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer  
    Massimo Cristofanilli, MD, The New England Journal of Medicine
  • From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing  
    William J Gradishar, Al B Benson, Massimo Cristofanilli, Allison W Kurian, Value in Health
  • Join now to see all

Authored Content

  • Minimal Residual Disease in Patients with Nonmetastatic Triple-Negative Breast CancerJuly 2020
  • From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingAugust 2018

Press Mentions

  • Undiagnosed Cancer Could Be the Next Health Crisis — and We Aren’t Ready
    Undiagnosed Cancer Could Be the Next Health Crisis — and We Aren’t ReadyDecember 12th, 2022
  • Syantra Appoints Dr. Massimo Cristofanilli to Its Scientific Advisory Board
    Syantra Appoints Dr. Massimo Cristofanilli to Its Scientific Advisory BoardOctober 27th, 2022
  • ANGLE Receives FDA Clearance for Parsortix
    ANGLE Receives FDA Clearance for ParsortixMay 25th, 2022
  • Join now to see all

Committees

  • Member, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present

Professional Memberships

Other Languages

  • Italian

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AmeriHealth Direct POS
    Amerihealth HMO
    AmeriHealth PPO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    First Health PPO
    Great West PPO
    IBC Keystone HMO / POS
    IBC Personal Choice PPO
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment